Treffer 1 - 4 von 4 für Suche 'Sameera Govindaraju Govindaraju', Suchdauer: 0,59s Treffer weiter einschränken
  1. 1
    Compliance and clinical benefit of deferasirox granule and dispersible tablet formulation in pediatric patients with transfusional iron overload: in a randomized, open-label, multicenter, phase II study

    Compliance and clinical benefit of deferasirox granule and dispersible tablet formulation in pediatric patients with transfusional iron overload: in a randomized, open-label, multi... von Taher, Ali T, Wali, Yasser, Cruz, Maria Cecilia, Charoenkwan, Pimlak, Aydinok, Yesim, Werner, Olena, Govindaraju, Sameera, Romen, Fabian, Viprakasit, Vip

    Veröffentlicht in Haematologica (Roma)

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    An open‐label, multicenter, efficacy, and safety study of deferasirox in iron‐overloaded patients with non‐transfusion‐dependent thalassemia (THETIS): 5‐year results

    An open‐label, multicenter, efficacy, and safety study of deferasirox in iron‐overloaded patients with non‐transfusion‐dependent thalassemia (THETIS): 5‐year results von Lai, Yong‐Rong, Cappellini, Maria Domenica, Aydinok, Yesim, Porter, John, Karakas, Zeynep, Viprakasit, Vip, Siritanaratkul, Noppadol, Kattamis, Antonis, Liu, Rongrong, Izquierdo, Miguel, Lasher, Janet, Govindaraju, Sameera, Taher, Ali

    Veröffentlicht in American journal of hematology

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Testing the significance of crossover receiver operating characteristic curves in the presence of multiple markers

    Testing the significance of crossover receiver operating characteristic curves in the presence of multiple markers von Sameera Govindaraju Govindaraju, Vishnu Vardhan Rudravaram


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  4. 4
    Five‐year survival follow‐up of a phase III randomised trial comparing ofatumumab versus physicians' choice for bulky fludarabine‐refractory chronic lymphocytic leukaemia: a short report

    Five‐year survival follow‐up of a phase III randomised trial comparing ofatumumab versus physicians' choice for bulky fludarabine‐refractory chronic lymphocytic leukaemia: a short... von Miklos, Udvardy, Strugov, Vladimir, Lewerin, Catharina, Grosicki, Sebastian, Mazur, Grzegorz, Steurer, Michael, Montillo, Marco, Kryachok, Irina, Middeke, Jan M., Rekhtman, Grygoriy, Stefanelli, Tommaso, Vincent, Ghislaine, Govindaraju, Sameera, Österborg, Anders

    Veröffentlicht in British journal of haematology

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: